Tags: Policy



Issue Summary: Modernization of Cosmetics Regulation Act of 2022

The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) significantly expands FDA’s rulemaking and enforcement authority over cosmetics and creates substantial new compliance obligations for manufacturers, packers, and distributors of cosmetics intended for sale in the United States.

March 30, 2023

Issue Summary: TSCA Fees Rule

The Toxic Substances Control Act (TSCA) including the 2016 Lautenberg Chemical Safety Act (LCSA) amendments grant the Environmental Protection Agency (EPA) the authority to collect fees from chemical manufacturers and importers to offset up to 25% of the costs associated with the overall implementation and administration of TSCA.

January 20, 2023


SOCMA Launches Policy Webinar Series in April

As the specialty chemicals industry anticipates new policy and regulations coming under the Biden Administration, the Society of Chemical Manufacturers & Affiliates (SOCMA) is hosting its Policy Webinar Series throughout April to focus these key topics that are crucial to its membership and the value chain.

March 30, 2021


SOCMA Seeks Member Input on Chinese-origin Medical-Care Products

The Office of the U.S. Trade Representative (USTR) has announced that USTR is requesting public comments by June 25, 2020 on further modifications to remove Section 301 duties from additional Chinese-origin medical-care products, including pharmaceuticals and chemicals to make pharmaceuticals. SOCMA will submit comments to the docket and as such, requests input from members via the SOCMA 301 COVID-19 Data Sheet (page 3) for inclusion in SOCMA 301 COVID-19 Comments.

March 31, 2020

SOCMA Comments to U.S. EPA: TSCA New Chemical Determinations

SOCMA appreciates the opportunity to submit comments on the U.S. Environmental Protection Agency’s framework document entitled: “TSCA New Chemical Determinations: A Working Approach for Making Determinations under TSCA Section 5”.

February 18, 2020